AU2002230217A1 - Tablets quickly disintegrated in oral cavity - Google Patents
Tablets quickly disintegrated in oral cavityInfo
- Publication number
- AU2002230217A1 AU2002230217A1 AU2002230217A AU2002230217A AU2002230217A1 AU 2002230217 A1 AU2002230217 A1 AU 2002230217A1 AU 2002230217 A AU2002230217 A AU 2002230217A AU 2002230217 A AU2002230217 A AU 2002230217A AU 2002230217 A1 AU2002230217 A1 AU 2002230217A1
- Authority
- AU
- Australia
- Prior art keywords
- oral cavity
- quickly disintegrated
- tablets quickly
- tablets
- disintegrated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000214 Mouth Anatomy 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-038343 | 2001-02-15 | ||
JP2001038343 | 2001-02-15 | ||
PCT/JP2002/001140 WO2002064119A1 (en) | 2001-02-15 | 2002-02-12 | Tablets quickly disintegrated in oral cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002230217A1 true AU2002230217A1 (en) | 2003-02-20 |
AU2002230217B2 AU2002230217B2 (en) | 2005-02-17 |
Family
ID=18901333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002230217A Ceased AU2002230217B2 (en) | 2001-02-15 | 2002-02-12 | Tablets quickly disintegrated in oral cavity |
Country Status (12)
Country | Link |
---|---|
US (1) | US7927623B2 (en) |
EP (1) | EP1366760B1 (en) |
JP (1) | JP4179784B2 (en) |
KR (1) | KR100750554B1 (en) |
CN (1) | CN100372536C (en) |
AT (1) | ATE472319T1 (en) |
AU (1) | AU2002230217B2 (en) |
CA (1) | CA2437754C (en) |
DE (1) | DE60236850D1 (en) |
MX (1) | MXPA03007283A (en) |
NZ (1) | NZ527585A (en) |
WO (1) | WO2002064119A1 (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03010119A (en) * | 2001-05-09 | 2005-03-07 | Bayer Healthcare Ag | Novel use of 2-phenyl-substituted imidazotriazinones. |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
EP1552851A1 (en) * | 2002-06-10 | 2005-07-13 | Dainippon Pharmaceutical Co., Ltd. | Rapidly disintegrating tablet and process for producing the same |
DE10232113A1 (en) * | 2002-07-16 | 2004-01-29 | Bayer Ag | Medicinal products containing vardenafil hydrochloride trihydrate |
EA009985B1 (en) | 2003-03-10 | 2008-04-28 | Никомед Гмбх | Novel process for the preparation of roflumilast |
GB0317663D0 (en) * | 2003-07-29 | 2003-09-03 | Astrazeneca Ab | Pharmaceutical composition |
CN1913876B (en) * | 2003-12-09 | 2013-06-26 | 大日本住友制药株式会社 | Drug-containing grains and solid preparation containing the grains |
KR20140104986A (en) * | 2004-02-17 | 2014-08-29 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
DE102004023069A1 (en) * | 2004-05-11 | 2005-12-08 | Bayer Healthcare Ag | New dosage forms of the PDE 5 inhibitor vardenafil |
DE102005001989A1 (en) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenous formulations of PDE inhibitors |
DE102005009240A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with improved pharmacokinetic properties |
DE102005009241A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with controlled bioavailability |
CA2601250C (en) * | 2005-03-16 | 2014-10-28 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
KR20080031208A (en) * | 2005-05-25 | 2008-04-08 | 트랜스셉트 파마슈티칼스, 인코포레이티드 | Solid compositions and methods for treating middle-of-the night insomnia |
US7834201B2 (en) | 2005-06-22 | 2010-11-16 | H. Lundbeck A/S | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
KR101011278B1 (en) * | 2005-07-22 | 2011-01-28 | 미쓰비시 타나베 파마 코퍼레이션 | Rapidly disintegratable oral tablet |
BRPI0616633A2 (en) * | 2005-09-29 | 2011-06-28 | Bayer Healthcare Ag | pde inhibitors and combinations thereof for the treatment of urological disorders |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
WO2007091856A1 (en) * | 2006-02-10 | 2007-08-16 | Lg Household & Health Care Ltd. | In-situ melting and gelling tablet composition for oral care |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
US8765178B2 (en) | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
CA2673458A1 (en) * | 2006-12-21 | 2008-07-03 | Mallinckrodt Inc. | Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients |
WO2008081891A1 (en) * | 2006-12-28 | 2008-07-10 | Takeda Pharmaceutical Company Limited | Orally disintegrating solid preparation |
CN101711153A (en) * | 2007-06-13 | 2010-05-19 | 拜耳先灵制药股份公司 | The PDE inhibitor that is used for the treatment of acoustic trauma |
JP5557832B2 (en) * | 2008-03-18 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | Substituted 4-hydroxypyridine-5-carboxamide |
JP5594285B2 (en) * | 2009-03-16 | 2014-09-24 | ニプロ株式会社 | Orally disintegrating tablets |
CN102387833B (en) * | 2009-03-20 | 2016-01-13 | 因卡伯实验室有限责任公司 | Solid drugs administration device |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
MX2013000284A (en) | 2010-07-09 | 2013-03-18 | Teijin Pharma Ltd | Orally disintegrating tablet. |
US9011912B2 (en) | 2010-10-07 | 2015-04-21 | Abon Pharmaceuticals, Llc | Extended-release oral dosage forms for poorly soluble amine drugs |
JP6245786B2 (en) * | 2011-10-17 | 2017-12-13 | 大同化成工業株式会社 | Pharmaceutical binding agent and preparation using the binding agent |
HRP20211606T1 (en) | 2012-02-21 | 2022-01-21 | Towa Pharmaceutical Europe, S.L. | Oral pharmaceutical compositions of dabigatran etexilate |
JP5292520B1 (en) * | 2013-02-13 | 2013-09-18 | アピ株式会社 | Royal jelly-containing tablet and method for producing the same |
ES2843576T3 (en) * | 2016-02-05 | 2021-07-19 | Tiense Suikerraffinaderij Nv | Pearl sugar; pearl sugar preparation procedure |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4820103B1 (en) | 1968-05-06 | 1973-06-19 | ||
US5073048A (en) * | 1987-07-06 | 1991-12-17 | Asahi Kogaku Kogyo K.K. | Optical fiber bundle |
DE3827214A1 (en) * | 1988-08-11 | 1990-02-15 | Roehm Gmbh | RETARDED MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF |
JP3069458B2 (en) * | 1992-01-29 | 2000-07-24 | 武田薬品工業株式会社 | Orally disintegrating tablet and production method thereof |
US5254355A (en) * | 1992-05-29 | 1993-10-19 | Kraft General Foods, Inc. | Process for beverage tablets and products therefrom |
GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
GB9514465D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
JP3187657B2 (en) | 1994-07-08 | 2001-07-11 | 株式会社三共製作所 | Tablet manufacturing method and device |
JP3067125B2 (en) | 1994-11-22 | 2000-07-17 | 田辺製薬株式会社 | Easy-to-take nucleated tablet-type preparation |
GB9423911D0 (en) | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
DE19501481A1 (en) | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,8-disubstituted quinazolinones |
DE19501480A1 (en) * | 1995-01-19 | 1996-07-25 | Bayer Ag | 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one |
DE19501482A1 (en) * | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,9-disubstituted purine-6-ones |
EP0820441B1 (en) * | 1995-04-10 | 2002-06-26 | Fujisawa Pharmaceutical Co., Ltd. | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
CA2221351A1 (en) * | 1995-05-18 | 1996-11-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Cyclohexyl dihydrobenzofuranes |
CA2221357A1 (en) * | 1995-05-18 | 1996-11-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenyl dihydrobenzofuranes |
GB9514473D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Chemical compounds |
GB9514464D0 (en) * | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
JPH0948726A (en) * | 1995-08-07 | 1997-02-18 | Tanabe Seiyaku Co Ltd | Rapidly disintegrating preparation in mouth cavity and its production |
DE19541264A1 (en) * | 1995-11-06 | 1997-05-07 | Bayer Ag | Purin-6-one derivatives |
US6191138B1 (en) * | 1996-01-31 | 2001-02-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines |
US6127378A (en) * | 1996-03-26 | 2000-10-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines substituted in the 6 position |
US6087311A (en) * | 1996-12-06 | 2000-07-11 | The Proctor & Gamble Company | Coated detergent tablet |
AU6230098A (en) | 1997-02-27 | 1998-09-18 | Tanabe Seiyaku Co., Ltd. | Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors |
JPH10298062A (en) | 1997-04-24 | 1998-11-10 | Pfizer Pharmaceut Co Ltd | Rapidly dissolving type tablet in oral cavity |
JP3296412B2 (en) | 1997-04-25 | 2002-07-02 | 田辺製薬株式会社 | Molded preparation and its manufacturing method |
TW580397B (en) | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
JP4939680B2 (en) * | 1997-05-27 | 2012-05-30 | 武田薬品工業株式会社 | Solid preparation |
JP3591801B2 (en) * | 1997-06-19 | 2004-11-24 | 田辺製薬株式会社 | Manufacturing method of oral disintegrating preparation |
WO1999004758A1 (en) | 1997-07-25 | 1999-02-04 | Elan Corporation Plc | A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
US6037346A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Inc. | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
DK1736144T3 (en) * | 1998-05-18 | 2015-12-07 | Takeda Pharmaceutical | Orally disintegrating tablets. |
JP2000095759A (en) | 1998-07-21 | 2000-04-04 | Takeda Chem Ind Ltd | Tricyclic compound, its production, and phosphodiesterase inhibitor |
ATE481090T1 (en) * | 1998-07-28 | 2010-10-15 | Takeda Pharmaceutical | EASILY DISSOLVING SOLID PREPARATION |
JP2000072751A (en) | 1998-08-26 | 2000-03-07 | Tanabe Seiyaku Co Ltd | Isoquinolinone derivative |
JP2000072675A (en) | 1998-08-26 | 2000-03-07 | Tanabe Seiyaku Co Ltd | Pharmaceutical composition |
UA67802C2 (en) | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION |
GB9823103D0 (en) | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
GB9823101D0 (en) | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
JP2000128774A (en) * | 1998-10-26 | 2000-05-09 | Tanabe Seiyaku Co Ltd | Production of globular, fine grain including medicine |
AU3574500A (en) * | 1999-03-25 | 2000-10-16 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
BRPI0014526C1 (en) | 1999-09-16 | 2021-05-25 | Mitsubishi Tanabe Pharma Corp | cyclic compounds of six elements containing aromatic nitrogen, pharmaceutical composition and use thereof |
-
2002
- 2002-02-12 NZ NZ527585A patent/NZ527585A/en not_active IP Right Cessation
- 2002-02-12 US US10/468,208 patent/US7927623B2/en not_active Expired - Fee Related
- 2002-02-12 AU AU2002230217A patent/AU2002230217B2/en not_active Ceased
- 2002-02-12 MX MXPA03007283A patent/MXPA03007283A/en active IP Right Grant
- 2002-02-12 KR KR1020037010747A patent/KR100750554B1/en not_active IP Right Cessation
- 2002-02-12 DE DE60236850T patent/DE60236850D1/en not_active Expired - Lifetime
- 2002-02-12 CN CNB028050703A patent/CN100372536C/en not_active Expired - Fee Related
- 2002-02-12 JP JP2002033547A patent/JP4179784B2/en not_active Expired - Fee Related
- 2002-02-12 AT AT02711460T patent/ATE472319T1/en not_active IP Right Cessation
- 2002-02-12 EP EP02711460A patent/EP1366760B1/en not_active Expired - Lifetime
- 2002-02-12 CA CA2437754A patent/CA2437754C/en not_active Expired - Fee Related
- 2002-02-12 WO PCT/JP2002/001140 patent/WO2002064119A1/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002230217A1 (en) | Tablets quickly disintegrated in oral cavity | |
AU2002255321A1 (en) | Tablets quickly disintegrating in the oral cavity and process for producing the same | |
AU2002255321A2 (en) | Tablets quickly disintegrating in the oral cavity and process for producing the same | |
EP1674083A4 (en) | Tablet quickly disintegrating in oral cavity | |
EP1120120A4 (en) | Tablets immediately disintegrating in the oral cavity | |
AU6089200A (en) | Rapid immediate release oral dosage form | |
AU2002244154A1 (en) | Divalproex sodium tablets | |
AU2001268743A1 (en) | Oral care compositions comprising chlorite and methods | |
AU2001248751A1 (en) | Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity | |
AU2001294250A1 (en) | Medicinal compositions quickly disintegrating in the oral cavity and process forproducing the same | |
AU2003238670A1 (en) | Fast disintegrating oral dosage forms | |
AU2002221096A1 (en) | Medicinal compositions improved in solublity in water | |
AU2001259693A1 (en) | Oral devices | |
AU2002214324A1 (en) | Medicinal compositions | |
GB0025888D0 (en) | Jaw crusher unit | |
AU2001290239A1 (en) | Medicinal composition | |
AU2002343025A1 (en) | Improvements in footwear | |
AU2003284942A1 (en) | Oral extended release tablets and methods of making and using the same | |
AU2003218261A1 (en) | Improvements in pharmaceutical discovery and development | |
AU2001280830A1 (en) | Paroxetine tablets and capsules | |
AU2001241187A1 (en) | Sustained release oral preparations | |
AU5428800A (en) | Tablets quickly disintegrating in mouth | |
AU2003211128A1 (en) | Transgenic production in saliva | |
AU2003206471A1 (en) | Dental wedge | |
AU2001278487A1 (en) | Oral composition |